文献速递慢病防控与筛查卫生政策与健康促进

COBRA-BPS多组分高血压管理项目的预算影响与成本效果分析

Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka.
PubMed 文献 · Lancet Glob Health · 2021-03-19

COBRA-BPS是由社区卫生工作者主导的多组分高血压管理项目,在孟加拉国、巴基斯坦和斯里兰卡农村社区已显示可降低收缩压。本研究基于整群随机试验,前瞻性量化2年成本,评估扩大规模至所有合格成人的预算需求与增量成本效果比。

要点

  • COBRA-BPS在孟加拉国、巴基斯坦、斯里兰卡农村地区均具成本效果。
  • 增量成本效果比分别为3430、2270、4080美元/避免的心血管伤残调整生命年。

核心结论

  • COBRA-BPS扩大规模成本低且具成本效果,可作为南亚及其他类似中低收入国家农村社区应对心血管疾病流行的优先干预策略。

研究设计与样本

  • 基于整群随机试验COBRA-BPS,在孟加拉国、巴基斯坦、斯里兰卡30个农村社区纳入40岁及以上高血压个体,前瞻性量化基线和2年试验期间成本,从卫生部(公共支付者)视角估算扩大规模至所有合格成人的增量成本。

主要发现

  • 增量成本效果比分别为每避免一个心血管伤残调整生命年3430美元(孟加拉国)、2270美元(巴基斯坦)、4080美元(斯里兰卡),均低于WHO-CHOICE阈值(人均GDP三倍)。

关键数值与推荐

  • 成本效果阈值采用WHO-CHOICE人均GDP三倍标准,三国增量成本效果比均低于该阈值。

临床怎么用

  • 在社区卫生工作者覆盖的中低收入国家农村地区,可将COBRA-BPS作为优先干预措施推广,以应对心血管疾病流行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COBRA-BPS (Control of Blood Pressure and Risk Attenuation-Bangladesh, Pakistan, Sri Lanka), a multi-component hypertension management programme that is led by community health workers, has been shown to be efficacious at reducing systolic blood pressure in rural communities in Bangladesh, Pakistan, and Sri Lanka. In this study, we aimed to assess the budget required to scale up the programme and the incremental cost-effectiveness ratios. METHODS: In a cluster-randomised trial of COBRA-BPS, individuals aged 40 years or older with hypertension who lived in 30 rural communities in Bangladesh, Pakistan, and Sri Lanka were deemed eligible for inclusion. Costs were quantified prospectively at baseline and during 2 years of the trial. All costs, including labour, rental, materials and supplies, and contracted services were recorded, stratified by programme activity. Incremental costs of scaling up COBRA-BPS to all eligible adults in areas covered by community health workers were estimated from the health ministry (public payer) perspective. FINDINGS: Between April 1, 2016, and Feb 28, 2017, 11 510 individuals were screened and 2645 were enrolled and included in the study. Participants were examined between May 8, 2016, and March 31, 2019. The first-year per-participant costs for COBRA-BPS were US$10·65 for Bangladesh, $10·25 for Pakistan, and $6·42 for Sri Lanka. Per-capita costs were $0·63 for Bangladesh, $0·29 for Pakistan, and $1·03 for Sri Lanka. Incremental cost-effectiveness ratios were $3430 for Bangladesh, $2270 for Pakistan, and $4080 for Sri Lanka, per cardiovascular disability-adjusted life year averted, which showed COBRA-BPS to be cost-effective in all three countries relative to the WHO-CHOICE threshold of three times gross domestic product per capita in each country. Using this threshold, the cost-effectiveness acceptability curves predicted that the probability of COBRA-BPS being cost-effective is 79·3% in Bangladesh, 85·2% in Pakistan, and 99·8% in Sri Lanka. INTERPRETATION: The low cost of scale-up and the cost-effectiveness of COBRA-BPS suggest that this programme is a viable strategy for responding to the growing cardiovascular disease epidemic in rural communities in low-income and middle-income countries where community health workers are present, and that it should qualify as a priority intervention across rural settings in south Asia and in other countries with similar demographics and health systems to those examined in this study. FUNDING: The UK Department of Health and Social Care, the UK Department for International Development, the Global Challenges Research Fund, the UK Medical Research Council, Wellcome Trust.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Finkelstein EA, Krishnan A, Naheed A, et al. Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka. Lancet Glob Health. 2021. PMID: 33751956. doi:10.1016/S2214-109X(21)00033-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。